With the participation of CEO Global Longevity Institute Elina Manzhalii, a series of programs on hepatic longevity began on a leading television channel.
According to the planned Global Longevity project order, the international audit company began work on a large-scale audit study of all project assets (preliminary total cost of about $ 25 000 000), their assessment expertise with analysis of the growth prospects of the project assets. The final conclusion will be available soon.
Happy New Year and Merry Christmas to all project staff and partners!
In accordance with the plan for the development of Global Longevity PharmaceuticalsTM, we invested the project funds in a new pharmacological complex located in an alpine forest region with a huge range of high-quality medicinal plants and herbs.
In the near future we will be publishing the latest scientific article by the CEO Global Longevity Elina Manzhalii on the fundamental scientific foundations of the Global Longevity project, as well as her large interview on the development of the project to one of the world profile publications.
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.